Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
RecruitingOBSERVATIONAL
Enrollment
377
Participants
Timeline
Start Date
October 25, 2023
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2028
Conditions
Non-small Cell Lung Cancer
Trial Locations (1)
200433
RECRUITING
Shanghai Pulmonary Hospital, Shanghai
All Listed Sponsors
lead
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
NCT05965024 - Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter